The Blood Screening market size is projected to reach a CAGR of 8.5% from 2020 to 2028.
Blood screening is a procedure or a diagnostic test which is used for the pre-diagnosis of any microbiology or viral infection in the body with the help of blood testing. The 3 main blood tests are 1. Complete blood count 2. Metabolic panel and 3. lipid panel. Blood Screening takes about 5-10 minutes for the full procedure but may take longer if the vein of the person is difficult to identify.
The increased incidents of infectious diseases along with the recent surge in demand for donated blood and more people getting involved in blood donations are some of the factors that have supported long-term expansion for Blood Screenings Market.
COVID-19 had a substantial negative effect on the market, as during the prevalent lockdown conditions the need for donated blood and the blood donation facilities both had been decreased.
North America is the most rapidly growing market and offers a huge opportunity for the industry, since the prevalence of infectious diseases has surged in the region along with the increased expenditure on the health care sector.
Insights are provided for each region and major countries within the regions
|
Report Feature |
Descriptions |
|---|---|
|
Growth Rate |
CAGR of 8.5% during the forecasting period, 2020-2028 |
|
Historical Data |
2017-2018 |
|
Forecast Years |
2020-2028 |
|
Base Year |
2019 |
|
Units Considered |
Revenue in USD billion and CAGR from 2022 to 2028 |
|
Report Segmentation |
Product & service, technology, end user and region. |
|
Report Attribute |
Market Revenue Sizing (Global, Regional and Country Level) Company Share Analysis, Market Dynamics, Company Profiling |
|
Regional Level Scope |
North America, Europe, Asia-Pacific, South America, and Middle East and Africa |
|
Country Level Scope |
U.S., Japan, Germany, U.K., China, India, Brazil, UAE, South Africa (50+ Countries Across the Globe) |
|
Companies Profiled |
Grifols , F. Hoffmann-La Roche Ltd. , Abbott Laboratories, Inc. , bioMérieux , Bio-Rad Laboratories, Inc. , Becton, Dickinson and Company , Beckman Coulter, Inc. , DiaSorin , Siemens Healthineers , Thermo Fisher Scientific, Inc. , Ortho Clinical Diagnostics Inc. , GE Healthcare , Merck KGaA , PerkinElmer , Bio-Techne Corporation , GFE , Enzo Biochem, Inc. , and Cepheid |
|
Available Customization |
In addition to the market data for Blood Screening s Market, Delvens offers client-centric report and customized according to the company’s specific demand and requirement. |
Blood Screening s Market is segmented into Product & service, technology, end user and region.
.png)
.png)
.png)
.png)
.png)
.png)